Avoro Capital Advisors LLC - Jun 30, 2025 SCHEDULE 13G/A Report for ARROWHEAD PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (ARWR)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: ARROWHEAD PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: ARWR
Shares outstanding: 139M shares
Disclosed Ownership: 11.5M shares
Ownership: 8.3%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 07:07 AM
Date of event: Jun 30, 2025
Previous filing: Feb 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	8.3%	11.5M	11.5M	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	8.3%	11.5M	11.5M	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually